Sign up
Pharma Capital

Eyecarrot Innovations helps kids see better thanks to its Binovi technology platform

Eyecarrot Innovations Corp (CVE:EYC; OTCMKTS:EYCCF) CEO Adam Cegielski tells Proactive Investors that the tech company is at the forefront of vision rehabilitation, with its technology platform that helps users see better.

Eyecarrot's Binovi platform uses mobile and cloud-based technology to streamline the treatment of vision performance issues and is marketed to vision care professionals.

Cegielski says there's been an increase in the number of children being affected by myopia (nearsightedness), particularly as more kids spend more time glued to their screens.

Cegielski says the software will help modernize the eye care profession. He adds that easy implementation is one of the strengths of the technology.

Cegielski says the technology can also be used for the enhancement of professional athletes' vision.


View full EYC profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.